Now accepting submissions
Editorial Board
Editors-in-Chief
- James L Kirkland, Mayo Clinic, USA
- Gordon J Lithgow, Buck Institute for Research on Aging, USA
- Janet M Lord, University of Birmingham, UK
Editorial Board
- Peter Adams, Cancer Research UK Beatson Labs, UK
- Richard Aspinall, Cranfield University, UK
- Steven Austad, University of Texas Health Science Center at San Diego, USA
- Mikhail V Blagosklonny, Roswell Park Cancer Institute, USA
- Martin Brand , Buck Institute for Research on Aging, USA
- Holly Brown-Borg, University of North Dakota, USA
- Anne Brunet, Stanford University, USA
- Ashley Bush, Harvard Medical School, USA
- Alexander Bürkle, University of Konstanz, Germany
- Rafael de Cabo, National Institute on Aging, USA
- Lynne Cox, University of Oxford, UK
- Eileen Crimmins, University of Southern California, USA
- Gerald de Haan, University of Groningen, Netherlands
- Ian Deary, University of Edinburgh, UK
- Monica Driscoll, Rutgers University, USA
- Deborah Dunn-Walters, Kings College London, UK
- Elissa Epel, University of California, San Francisco, USA
- Mandy Fain, University of Arizona College of Medicine, USA
- Richard Faragher, University of Brighton, UK
- Oscar Franco, University of Cambridge, UK
- Chris Fry, University of Surrey, UK
- David Gems, University College London, UK
- Matthew Gill, Scripps Research Institute, USA
- David Greenberg, Buck Institute for Research on Aging, USA
- Laura Haynes, Trudeau Institute, USA
- Jan Hoeijmakers, Erasmus Universiteit Rotterdam, Netherlands
- Yuji Ikeno, University of Texas Health Science Center at San Diego, USA
- Malcolm J Jackson, University of Liverpool, UK
- Matt Kaeberlein, University of Washington, USA
- Arnold Kahn, California Pacific Medical Center, San Francisco, USA
- Pankaj Kapahi, Buck Institute for Research on Aging, USA
- Kay-Tee Khaw, University of Cambridge, UK
- Sundeep Khosla, Mayo Clinic, USA
- Janice Kiecolt-Glaser, Ohio State University, USA
- David Kipling, Cardiff University, UK
- Susan A Lanham-New, University of Surrey, UK
- Nathan LeBrasseur, Mayo Clinic, USA
- Chris Link, University of Colorado at Boulder, USA
- Valter D Longo, University of Southern California, USA
- John Loughlin, Newcastle University, UK
- Victoria Lunyak , Buck Institute for Research on Aging, USA
- Jordan Miller, Mayo Clinic, USA
- Janko Nikolich-Zugich, University of Arizona College of Medicine, USA
- Ralph A Nixon, Nathan Kline Institute, USA
- Sinead O'Mahoney, Cardiff University, UK
- E Kenneth Parkinson, Queen Mary University of London, UK
- Graham Pawelec, University of Tübingen, Germany
- Charlotte Peterson, University of Kentucky, USA
- Scott Pletcher, University of Michigan, USA
- Thomas Rando, Stanford University, USA
- Avan Aihie Sayer, University of Southampton, UK
- Tim Skerry, Sheffield University, UK
- Tim Spector, King's College London, UK
- Richard Sprott, The Ellison Medical Foundation, USA
- Yousin Suh, Albert Einstein College of Medicine, USA
- Nektarios Tavernarakis, University of Crete, Greece
- G Neil Thomas, University of Birmingham, UK
- Heidi Tissenbaum, University of Massachusetts Medical School, USA
- Douglas Turnbull, University of Newcastle upon Tyne, UK
- Jan Vijg, Albert Einstein College of Medicine, USA
- Jeremy Walston, Johns Hopkins University School of Medicine, USA
- Dominic J Withers, Imperial College London, UK
- Thomas von Zglinicki, University of Newcastle, UK
Also of interest...
Researchers in the field of ageing may also find a new thematic series being published in Chemistry Central Journal 'Chemistry of Ageing' of interest. This series publishes articles related to the chemical processes of ageing, including a recently published article by Longevity & Healthspan Editorial Board Member David Kipling.
Aims & scope
Longevity & Healthspan is an open access, peer-reviewed, interdisciplinary journal that publishes articles on all aspects of aging biology in the context of healthy aging or age-related disease. More specifically, the journal emphasizes advancing understanding of how age-related changes in structure and function become risk factors for or accompany age-related diseases or conditions, and the biology underlying healthy aging and longevity.
Experimental approaches include biochemistry, molecular genetics, genome-wide association studies, cell biology, and interventional studies.
The journal welcomes articles in particular in the following areas:
- Development of criteria to define successful aging in humans or model organisms
- Development of genetically tractable animal models assessing healthspan or age-related conditions
- Interdisciplinary studies involving both aging and age-related disease specialists
- Studies of candidate genes or pathways that correlate with age-related conditions
- Studies on the biology of healthy aging and longevity
- Translational studies validating interventions to increase healthspan and/or longevity
Epidemiological studies and studies of interventions targeting age-related conditions with concurrent study of other age-associated end points will also be given consideration.
Aging represents the most important risk factor for chronic disease, frailty, and loss of independence, making an understanding of the mechanisms by which aging curtails healthspan and leads to disease highly desirable from both a social and economic standpoint. Longevity & Healthspan bridges the gap between research on the basic biology of aging and clinical dysfunction associated with the aging process.
Editors-in-Chief
James Kirkland
James Kirkland is Professor of Physiology and Medicine, Noaber Foundation Professor of Aging Research, and Director of the Robert and Arlene Kogod Center on Aging at the Mayo Clinic in Rochester, Minnesota. He received his MD from the University of Toronto, before undertaking a residency in internal medicine at Toronto General Hospital. He went on to obtain an MSc in Geriatric Medicine from the University of Manchester, UK, before returning to the University of Toronto to study for a PhD at the Institute of Medical Science.
Gordon Lithgow
Gordon Lithgow is Principal Investigator and Director of the Interdisciplinary Research Consortium on Geroscience at the Buck Institute for Research on Aging in Novato, California. He received his PhD in Genetics from the University of Glasgow, Scotland, before undertaking postdoctoral training at the Institute for Behavioral Genetics, University of Colorado, Boulder. Returning to the UK, he became Senior Lecturer in Molecular Gerontology at the University of Manchester, before moving to the Buck Institute in 2001.
Janet Lord
Janet Lord is Professor of Immune Cell Biology and Director of the Centres for Healthy Ageing Research and Translational Inflammation Research at the University of Birmingham, UK. She gained her PhD from the University of Aston, where she investigated the link between obesity, diabetes, and ageing, later going on to look at signalling pathways involved in the regulation of insulin secretion at Oxford University, and uncovering the key role of protein kinase C in this process. Returning to the University of Birmingham, she was awarded a Royal Society University Fellowship in 1989, and set up her own laboratory investigating cell signalling in immune cells and its dysregulation in disease.
Email updates
Receive periodic news and updates relating to this journal.